These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 27154961)

  • 1. The Effects of Medicare Part D on Health Outcomes of Newly Covered Medicare Beneficiaries.
    Diebold J
    J Gerontol B Psychol Sci Soc Sci; 2018 Jun; 73(5):890-900. PubMed ID: 27154961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vital Signs: Disparities in Antihypertensive Medication Nonadherence Among Medicare Part D Beneficiaries - United States, 2014.
    Ritchey M; Chang A; Powers C; Loustalot F; Schieb L; Ketcham M; Durthaler J; Hong Y
    MMWR Morb Mortal Wkly Rep; 2016 Sep; 65(36):967-76. PubMed ID: 27632693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of Medicare Part D on medication adherence among older adults enrolled in Medicare-Advantage products.
    Zhang Y; Lave JR; Donohue JM; Fischer MA; Chernew ME; Newhouse JP
    Med Care; 2010 May; 48(5):409-17. PubMed ID: 20393360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of an integrated adherence program aimed to increase Medicare Part D star rating measures.
    Leslie RS; Tirado B; Patel BV; Rein PJ
    J Manag Care Spec Pharm; 2014 Dec; 20(12):1193-203. PubMed ID: 25443513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-related medication nonadherence among beneficiaries with depression following Medicare Part D.
    Zivin K; Madden JM; Graves AJ; Zhang F; Soumerai SB
    Am J Geriatr Psychiatry; 2009 Dec; 17(12):1068-76. PubMed ID: 20104063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between dispensing channel and medication adherence among medicare beneficiaries taking medications to treat diabetes, high blood pressure, or high blood cholesterol.
    Iyengar RN; Balagere DS; Henderson RR; LeFrancois AL; Rabbitt RM; Frazee SG
    J Manag Care Spec Pharm; 2014 Aug; 20(8):851-61. PubMed ID: 25062079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-Related Medication Nonadherence and Cost-Saving Behaviors Among Patients With Glaucoma Before and After the Implementation of Medicare Part D.
    Blumberg DM; Prager AJ; Liebmann JM; Cioffi GA; De Moraes CG
    JAMA Ophthalmol; 2015 Sep; 133(9):985-96. PubMed ID: 26042393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of statin adherence among beneficiaries in MA-PD plans versus PDPs.
    Jung K; McBean AM; Kim JA
    J Manag Care Pharm; 2012 Mar; 18(2):106-15. PubMed ID: 22380470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antihypertensive adherence and outcomes among community-dwelling Medicare beneficiaries: the Atherosclerosis Risk in Communities Study.
    Federspiel JJ; Sueta CA; Kucharska-Newton AM; Beyhaghi H; Zhou L; Virani SS; Rodgers JE; Chang PP; Stearns SC
    J Eval Clin Pract; 2018 Feb; 24(1):48-55. PubMed ID: 27807921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Medicare Part D on Ethnoracial Disparities in Antidementia Medication Use.
    Lind KE; Hildreth K; Lindrooth R; Morrato E; Crane LA; Perraillon MC
    J Am Geriatr Soc; 2018 Sep; 66(9):1760-1767. PubMed ID: 30095169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How Much Does Medication Nonadherence Cost the Medicare Fee-for-Service Program?
    Lloyd JT; Maresh S; Powers CA; Shrank WH; Alley DE
    Med Care; 2019 Mar; 57(3):218-224. PubMed ID: 30676355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiparkinson drug use and adherence in medicare part D beneficiaries with Parkinson's disease.
    Wei YJ; Palumbo FB; Simoni-Wastila L; Shulman LM; Stuart B; Beardsley R; Brown C
    Clin Ther; 2013 Oct; 35(10):1513-1525.e1. PubMed ID: 24139423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-income Medicare beneficiaries and their experiences with the part D prescription drug benefit.
    Rudolph NV; Montgomery MA
    Inquiry; 2010; 47(2):162-72. PubMed ID: 20812464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Geographic variation in medication adherence in commercial and Medicare part D populations.
    Couto JE; Panchal JM; Lal LS; Bunz TJ; Maesner JE; O'Brien T; Khan T
    J Manag Care Spec Pharm; 2014 Aug; 20(8):834-42. PubMed ID: 25062077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medication use and adherence among elderly Medicare beneficiaries with diabetes enrolled in Part D and retiree health plans.
    Stuart B; Simoni-Wastila L; Yin X; Davidoff A; Zuckerman IH; Doshi J
    Med Care; 2011 May; 49(5):511-5. PubMed ID: 21422956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-related nonadherence in the Medicare program: the impact of Part D.
    Kennedy JJ; Maciejewski M; Liu D; Blodgett E
    Med Care; 2011 May; 49(5):522-6. PubMed ID: 21430574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adherence to tyrosine kinase inhibitors among Medicare Part D beneficiaries with chronic myeloid leukemia.
    Shen C; Zhao B; Liu L; Shih YT
    Cancer; 2018 Jan; 124(2):364-373. PubMed ID: 28976559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in Medication Management After a Diagnosis of Cancer Among Medicare Beneficiaries With Diabetes.
    Stuart BC; Davidoff AJ; Erten MZ
    J Oncol Pract; 2015 Nov; 11(6):429-34. PubMed ID: 26105669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of provider mailings on medication adherence by Medicare Part D members.
    Borah BJ; Qiu Y; Shah ND; Gleason PP
    Healthc (Amst); 2016 Sep; 4(3):207-16. PubMed ID: 27637828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medicare beneficiaries' knowledge of Part D prescription drug program benefits and responses to drug costs.
    Hsu J; Fung V; Price M; Huang J; Brand R; Hui R; Fireman B; Newhouse JP
    JAMA; 2008 Apr; 299(16):1929-36. PubMed ID: 18430912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.